Dr. Marcus Urey, MD
NPI: 1972820058
Total Payments
$269,056
2024 Payments
$108,060
Companies
19
Transactions
409
Medicare Patients
3,652
Medicare Billing
$451,196
Payment Breakdown by Category
Other$153,560 (57.1%)
Consulting$61,189 (22.7%)
Travel$38,675 (14.4%)
Food & Beverage$14,958 (5.6%)
Gifts$665.60 (0.2%)
Education$7.04 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $144,460 | 53 | 53.7% |
| Consulting Fee | $61,189 | 21 | 22.7% |
| Travel and Lodging | $38,675 | 135 | 14.4% |
| Food and Beverage | $14,958 | 190 | 5.6% |
| Honoraria | $9,100 | 6 | 3.4% |
| Gift | $665.60 | 2 | 0.2% |
| Education | $7.04 | 1 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$269,056
408 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $122,407 | 157 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $62,797 | 46 | $0 (2024) |
| PFIZER INC. | $39,867 | 32 | $0 (2024) |
| Akcea Therapeutics, Inc. | $18,726 | 30 | $0 (2020) |
| Edwards Lifesciences Corporation | $13,154 | 15 | $0 (2024) |
| Abbott Laboratories | $5,814 | 65 | $0 (2024) |
| ABIOMED | $3,134 | 29 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,202 | 16 | $0 (2019) |
| Tosoh Bioscience, Inc. | $665.60 | 2 | $0 (2017) |
| Boston Scientific Corporation | $640.04 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108,060 | 84 | AstraZeneca Pharmaceuticals LP ($61,908) |
| 2023 | $20,649 | 36 | Alnylam Pharmaceuticals Inc. ($18,160) |
| 2022 | $30,013 | 52 | Alnylam Pharmaceuticals Inc. ($27,723) |
| 2021 | $11,778 | 13 | Alnylam Pharmaceuticals Inc. ($10,869) |
| 2020 | $18,600 | 13 | Alnylam Pharmaceuticals Inc. ($7,067) |
| 2019 | $74,177 | 150 | Alnylam Pharmaceuticals Inc. ($44,633) |
| 2018 | $4,686 | 54 | Abbott Laboratories ($3,591) |
| 2017 | $1,092 | 7 | Tosoh Bioscience, Inc. ($665.60) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PFIZER INC. | VYNDAMAX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $81.20 | General |
| Category: Genetic Disease | ||||||
| 12/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $289.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $205.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2024 | PFIZER INC. | VYNDAMAX (Drug) | Travel and Lodging | In-kind items and services | $454.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2024 | PFIZER INC. | VYNDAMAX (Drug) | Travel and Lodging | In-kind items and services | $395.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,416.50 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $268.50 | General |
| 11/13/2024 | PFIZER INC. | VYNDAMAX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $134.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $171.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $397.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $235.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $228.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Consulting Fee | Cash or cash equivalent | $2,820.00 | General |
| Category: Genetic Disease | ||||||
| 09/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $287.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $284.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Travel and Lodging | In-kind items and services | $201.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 619 | 963 | $397,870 | $88,992 |
| 2022 | 13 | 590 | 1,144 | $488,671 | $114,597 |
| 2021 | 17 | 1,073 | 1,526 | $453,675 | $118,902 |
| 2020 | 17 | 1,370 | 1,850 | $509,051 | $128,704 |
Total Patients
3,652
Total Services
5,483
Medicare Billing
$451,196
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 217 | $53,816 | $13,762 | 25.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 62 | $56,482 | $10,755 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 98 | 132 | $46,002 | $9,847 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 61 | $32,949 | $9,026 | 27.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 83 | $29,465 | $8,065 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 48 | 48 | $32,616 | $6,915 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 72 | $26,390 | $6,893 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 53 | 58 | $28,079 | $6,865 | 24.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 49 | $22,932 | $4,599 | 20.1% |
| 93505 | Biopsy of heart muscle | Facility | 2023 | 23 | 26 | $25,558 | $4,283 | 16.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 37 | 39 | $9,672 | $2,622 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $7,328 | $1,466 | 20.0% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 14 | 14 | $13,202 | $1,441 | 10.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,434 | $1,206 | 18.7% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 11 | 29 | $5,394 | $932.35 | 17.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 46 | 47 | $1,551 | $314.43 | 20.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 364 | $129,220 | $30,972 | 24.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 21 | 87 | $72,474 | $15,648 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 93 | 128 | $55,552 | $15,505 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 93 | 117 | $34,515 | $7,882 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 52 | $28,127 | $7,825 | 27.8% |
| 93505 | Biopsy of heart muscle | Facility | 2022 | 30 | 42 | $41,286 | $7,793 | 18.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 47 | 47 | $27,025 | $7,052 | 26.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 36 | $24,768 | $5,893 | 23.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 96 | $23,808 | $5,705 | 24.0% |
About Dr. Marcus Urey, MD
Dr. Marcus Urey, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972820058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Urey, MD has received a total of $269,056 in payments from pharmaceutical and medical device companies, with $108,060 received in 2024. These payments were reported across 409 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($144,460).
As a Medicare-enrolled provider, Urey has provided services to 3,652 Medicare beneficiaries, totaling 5,483 services with total Medicare billing of $451,196. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease
- Location San Diego, CA
- Active Since 04/28/2010
- Last Updated 10/03/2017
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1972820058
Products in Payments
- ONPATTRO (Drug) $64,738
- WAINUA (Drug) $48,865
- AMVUTTRA (Drug) $37,274
- VYNDAQEL (Drug) $30,793
- TEGSEDI (Drug) $13,726
- VYNDAMAX (Drug) $6,250
- Impella (Device) $3,134
- CardioMEMS HF System (Device) $1,788
- HeartWare HVAD (Device) $1,202
- CentriMag (Device) $1,140
- HeartMate (Device) $939.07
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $692.67
- WATCHMAN (Device) $505.34
- CARDIOMEMS (Device) $444.49
- G8 Column (Medical Supply) $393.80
- G8 Elution Buffer No. 3, 800mL (Medical Supply) $271.80
- HeartMate 3 Left Ventricular Dev (Device) $230.89
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $207.97
- SherpaPak (Device) $162.73
- Circulatory Support (Device) $146.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in San Diego
Justin Parizo, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $11,841
Advanced Heart Failure and Transplant Cardiology $11,841
Quan Bui
Advanced Heart Failure and Transplant Cardiology — Payments: $8,179
Advanced Heart Failure and Transplant Cardiology $8,179
Dr. Nicholas Wettersten, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $3,627
Advanced Heart Failure and Transplant Cardiology $3,627
Hilary Shapiro
Advanced Heart Failure and Transplant Cardiology — Payments: $917.29
Advanced Heart Failure and Transplant Cardiology $917.29
Andrea Boettcher, Np, NP
Advanced Heart Failure and Transplant Cardiology — Payments: $852.76
Advanced Heart Failure and Transplant Cardiology $852.76
Antoinette Birs, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $636.46
Advanced Heart Failure and Transplant Cardiology $636.46